1. Introduction {#sec1}
===============

In the recent times, the problem of food safety is gaining importance in developed and developing countries. Major causes that are responsible for food toxicity include poor knowledge, malpractice during their preparation, the presence of bacteria, toxins or allergens in the food, and cross-contamination with harmful organisms [@bib1]. Many short-term (nausea, vomiting, weakness, diarrhea, mild fever and headache) and long-term (kidney failure, brain and nerve damage) health hazards may result from exposure to food toxicants. Therefore, efforts are being taken by various governmental and regulatory agencies (such as World Health Organization International Program on Chemical Safety, US Food and Drug Administration, US Environmental Protection Agency, Agency for Toxic Substances and Disease Registry, European Chemicals Agency, etc.) to publish evidences based on peer-reviewed scientific literature related to health assessments of chemicals.

Fenugreek (*Trigonella foenum graecum* L., family: Fabaceae) is one of the most promising traditional medicinal plants cultivated widely in India, Egypt, and Middle Eastern countries [@bib2]. Its leaves and seeds have been extensively used as medicine, spice, and vegetable in various pharmaceutical, nutraceutical, and functional food industries [@bib3]. Researchers have investigated multifaceted therapeutic benefits of fenugreek seeds against a variety of ailments including diabetes, cancer, hyperlipidemia, inflammation, neurotoxicity, hepatotoxicity, ulcers, wound, bacterial and fungal infections, weakness, and edema of the legs \[[@bib4], [@bib5]\]. Apart from its beneficial effects, many studies have also documented its toxicological profile \[[@bib6], [@bib7], [@bib8]\]. However, these published literature are diverse in nature. Although most studies suggested that its utilization is safe, some reported toxicity to the gastrointestinal and reproductive system. Additionally, researchers have published studies summarizing "evidence-based toxicology" results of fenugreek \[[@bib9], [@bib10]\]. However, the quality and reliability of toxicological studies of fenugreek were not assessed in the past. Furthermore, some of the reviews based on toxicological studies are diverse with respect to part of the fenugreek plant (whole, leaves, seeds), route (oral, intraperitoneal) administration, etc. These variations had a major impact on scientific conclusions and interpretations of these reviews. It may create confusion among the public regarding the safety of fenugreek seeds-based healthcare products.

To make a stronger and more reliable risk assessment on scientific basis, critical appraisal of reviews of scientific studies is needed. For such risk assessment, each evaluation of toxicological study needs to be based on standardized criteria, specifically designed for such purposes [@bib11]. In this view, National Academy of Sciences perceived the need to use standard criteria for the assessment of study quality of toxicological studies providing transparency and consistency of risk assessments [@bib12]. Additionally, experts from REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) and Society of Toxicology (SOT) suggested rating of the toxicological studies for quality and reliability during regulatory decisions \[[@bib13], [@bib14]\]. Thereafter, researchers have developed a reliable and objective assessment tool "ToxRTool" (**Tox**icological data **R**eliability Assessment **Tool**) to evaluate the quality of published toxicological studies [@bib15]. It is a validated, standardized, reproducible, and widely used tool that code toxicological studies based on reliability criteria [@bib15]. The identified studies using ToxRTool are "reliable" and can be included in a human health hazard assessment.

To the best of our knowledge, no systematic study has been carried out to determine the toxicological profile of fenugreek seed using an assessment tool like ToxRTool. Therefore, the present analysis was aimed to evaluate systematic evaluation of existing toxicological studies of fenugreek seed for their reliability and quality by using the ToxRTool.

2. Materials and methods {#sec2}
========================

This systematic review was conducted in line with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement [@bib16].

2.1. Search strategy {#sec2.1}
--------------------

We systematically searched the published scientific literature concerning toxicological studies on fenugreek seeds that are in English language. The literature identification process was performed by searching the following electronic databases: PubMed, EMBASE, the Cochrane Library, CPCI-S (Conference Proceedings Citation Index-Science), ICTRP (International Clinical Trials Registry Platform), Ovid, and Google Scholar for relevant publications by using Medical Subject Headings (MeSH) terms. These were systematically searched for titles and abstracts published between inception date of the database and October 2018 ([Table 1](#tbl1){ref-type="table"}). Spelling variations were also used. Additional articles were obtained through citation snowballing to locate primary sources. We also searched Clinicaltrials.gov to identify such studies. The results of this search identified additional relevant publications detailing primary research on the toxicity of fenugreek seed to be included in this review. Finally, references within the publications identified in the first two steps were reviewed to determine if any other relevant publications were overlooked, and a few unidentified publications were added to the list of publications to be evaluated as part of this review.Table 1The detailed Search strategy.Table 1Sr. No.SearchesResultsThe detailed Search strategy for PubMed ((("trigonella"\[MeSH Terms\] OR "trigonella"\[All Fields\] OR "fenugreek"\[All Fields\]) AND ("seeds"\[MeSH Tuerms\] OR "seeds"\[All Fields\] OR "seed"\[All Fields\])) OR (("trigonella"\[MeSH Terms\] OR "trigonella"\[All Fields\] OR ("trigonella"\[All Fields\] AND "foenum"\[All Fields\] AND "graecum"\[All Fields\]) OR "trigonella foenum graecum"\[All Fields\]) AND ("seeds"\[MeSH Terms\] OR "seeds"\[All Fields\] OR "seed"\[All Fields\])) OR (("trigonella"\[MeSH Terms\] OR "trigonella"\[All Fields\] OR ("trigonella"\[All Fields\] AND "foenum"\[All Fields\] AND "graecum"\[All Fields\]) OR "trigonella foenum graecum"\[All Fields\]) AND ("seeds"\[MeSH Terms\] OR "seeds"\[All Fields\] OR "seed"\[All Fields\])) OR ("trigonella"\[MeSH Terms\] OR "trigonella"\[All Fields\])) AND (("adverse effects"\[Subheading\] OR ("adverse"\[All Fields\] AND "effects"\[All Fields\]) OR "adverse effects"\[All Fields\]) OR ("toxicity"\[Subheading\] OR "toxicity"\[All Fields\]) OR ("poisoning"\[Subheading\] OR "poisoning"\[All Fields\] OR "poisoning"\[MeSH Terms\]) OR (Adverse\[All Fields\] AND event\[All Fields\])) AND (("humans"\[MeSH Terms\] OR "humans"\[All Fields\]) OR ("humans"\[MeSH Terms\] OR "humans"\[All Fields\] OR "human"\[All Fields\]) OR ("rats"\[MeSH Terms\] OR "rats"\[All Fields\] OR "rat"\[All Fields\]) OR ("mice"\[MeSH Terms\] OR "mice"\[All Fields\]) OR ("mice"\[MeSH Terms\] OR "mice"\[All Fields\] OR "mouse"\[All Fields\]))**The detailed Search strategy for Ovid**1.Fenugreek seed.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]3392.*Trigonella foenum-graecum* seed.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]723.*Trigonella foenum graecum* seed.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]724.Trigonella.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]12255.Adverse effects.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]19729326.Toxicity.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]10148567.Poisoning.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]1758238.Adverse event.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]1071929.(Humans or Human).mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]2002077810.(mice or mouse).mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]245963911.rat.mp. \[mp=ti, ab, tx, ct, sh, ot, nm, hw, fx, kf, px, rx, an, ui, sy\]135377612.1 or 2 or 3 or 4128713.5 or 6 or 7 or 8301263714.9 or 10 or 112198272215.12 and 13 and 1421616.Remove duplicates from 1520317.Limit 16 to English language201

2.2. Study inclusion criteria {#sec2.2}
-----------------------------

Titles and abstracts were identified as potentially eligible by two independent reviewers \[PT, AK\]. Titles and abstracts meeting the following inclusion criteria were selected for full-article (primary literature) review:•English language article•Studies reporting the toxicological profile of fenugreek seed (in the form of its extract, in the feed or isolated compound from fenugreek seed)•Outcome: toxicity endpoints

2.3. Exclusion criteria {#sec2.3}
-----------------------

The exclusion criteria were as follows: (1) studies where species were treated with fenugreek leaf/root/plant/flower (2) studies where species were treated with fenugreek seeds combined with other test compound (3) studies reporting only the chemistry of fenugreek seeds and no biological testing (e.g. phytochemistry work, analytical work) (4) studies reporting the protective action and/or mechanism of fenugreek seed against drug or disease induced toxicity (5) studies with no toxicity endpoints reported (6) secondary literature such as letters, reviews, editorials, commentary conference presentations, proceedings, abstracts, magazine, handbooks or white papers, (7) case series (sample size \<10 patients) or case reports (8) pharmacodynamic/pharmacokinetic studies, and (9) studies with full-text published in a language other than English. Review articles were excluded as well - however - their reference lists were searched for eligible articles. All retrieved full-text articles were again independently reviewed by the three reviewers (PAT, ADK, PW), according to the same predefined inclusion and exclusion criteria. When consensus regarding the eligibility could not be accomplished, an agreement was obtained through discussions with a fourth arbiter (SLB).

2.4. Quality assessment of the articles {#sec2.4}
---------------------------------------

The quality of each study included in the analysis was assessed using the "ToxRTool" [@bib15]. Three independent reviewers (PAT, ADK, PW) with risk assessment experience rated each publication of fenugreek seed involving toxicity testing. One of the raters (PW) is a qualified toxicologist and pathologist. Other two reviewers had participated in many GLP complaint and published toxicological studies on dietary ingredients in peer-reviewed journals. All the three reviewers were familiar with the ToxRTool before participation in this project. Each rater evaluated the articles using the ToxRTool downloaded from the European Commission\'s Joint Research Center website [@bib17]. The raters used the *in-vitro* ToxRTool spreadsheet to indicate whether 18 criteria were met in the following 5 areas: (1) test substance identification, (2) test system characterization, (3) study design description, (4) study results documentation, and (5) plausibility of study design and data. For *in-vivo* studies, the raters used a separate spreadsheet that listed 21 criteria in the same 5 areas that were used for *in-vitro* studies, except 'test system characterization' which is used for *in-vitro* studies instead of 'test organism characterization' that is used for *in-vivo* studies. The raters assigned score for each criterion on the appropriate spreadsheet as either a '1' ('yes-met') or a '0' ('no-not met').

2.5. Combined score, mean combined score, and standard deviation {#sec2.5}
----------------------------------------------------------------

A combined score was calculated for each rater and each study by summing the scores for all criteria for each study. A mean combined score (the average of all raters\' combined scores), and the standard deviation were also calculated.

2.6. Weighted score, mean weighted score, and standard deviation {#sec2.6}
----------------------------------------------------------------

A weighted score was calculated for each rater and study by summing the scores for all criteria (in which sum of scores only for red colored criteria was considered). The mean weighted scores (the average of weighted score of all raters), and standard deviation were also calculated.

2.7. Reliability categorization {#sec2.7}
-------------------------------

Reliability categorization of each study, based on the mean combined score and mean weighted score, was carried out according to a previously reported method [@bib18]. Based on the combined score, the ToxRTool assigned each study a reliability category 1 (reliable without restrictions), 2 (reliable with restrictions), 3 (not reliable). In determining the Weighted Score categorization, the ToxRTool identified certain criteria as critical. For this classification, if any individual 'critical' criterion was not met, a study could not be assigned as reliable, regardless of the study\'s Numerical Score ([Table 2](#tbl2){ref-type="table"}).Table 2Numerical score and weighted score reliability categorization.Table 2CategorizationTotal score (*in-vivo*)Total score (*in-vitro*)Consideration(Proposed) consequence118--2115--18Reliable without restrictionsUseful, check relevance for intended purpose213--1711--14Reliable with restrictionsPotentially useful, check relevance for the intended purpose3\<13 or not all red criteria met\<11 or not all red criteria metNot reliableGenerally, not to be used as key study, but depending on the shortcomings of the study it may still be useful in weight-of-evidence approaches or as supportive information4Not assignable: documentation insufficient (reviews, handbooks, other secondary sources)Generally, not to be used as a key study, but depending on the shortcomings of the study it may still be useful in weight-of-evidence approaches or as supportive information. (This category is not an outcome of this evaluation tool)

2.8. Calculating inter-rater consistency for each criterion {#sec2.8}
-----------------------------------------------------------

To determine which criteria had low agreement across raters and were therefore problematic, an inter-rater consistency value was calculated for each criterion. The Cronbach\'s Alpha coefficient was selected to measure inter-rater consistency, as each performs reasonably well in the presence of high and low agreement.

2.9. Data analysis {#sec2.9}
------------------

Data were analyzed by using the SPSS software. The data of numerical score and weighted score were presented as the mean and standard deviation (SD). The internal consistency and reliability of the factors were evaluated using the Cronbach\'s Alpha. The data of administered dosage form and guideline followed were analyzed by one-way analysis of variance (ANOVA) with Bonferroni\'s multiple range tests for post hoc analysis. A value of *p* \< 0.05 was considered to be statistically significant.

3. Results {#sec3}
==========

3.1. Summary of included studies {#sec3.1}
--------------------------------

As shown in [Fig. 1](#fig1){ref-type="fig"} (PRISMA flow chart), the database searches for "fenugreek seed toxicity" initially yielded 436 results. After duplicates were removed and reports screened by title, keywords, and abstract, they were screened for inclusion and exclusion. After screening of title or abstract, 376 of these (Case Study/Series (2), Chemistry of fenugreek seed (77), Conference presentation (11), Copy/duplicate (1), In combination with other drugs (22), No toxicity endpoints reported (23), Parts other than seeds (8), Protective action against toxicity (200) and Review/editorial (32)) were excluded. Further, based on the full-text screening, 15 studies (In combination with other drugs (4) and no toxicity endpoints reported (11)) were excluded. According to the Klimisch categories of ToxRTool, the category code of these 391 (89.67%) studies were "4" which indicates that a paper is "not assignable" because it does not contain any primary data. Remaining 45 (10.33%) studies were included for quantitative analysis by ToxRTool \[[@bib6], [@bib7], [@bib8], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43], [@bib44], [@bib45], [@bib46], [@bib47], [@bib48], [@bib49], [@bib50], [@bib51], [@bib52], [@bib53], [@bib54], [@bib55], [@bib56], [@bib57], [@bib58], [@bib59]\].Fig. 1PRISMA flow diagram depicting the selection of studies for systematic review for ToxRTool evaluation.Fig. 1

The primary findings from the included *in-vivo* and *in-vitro* studies are summarized in Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}. The assignable toxicology publications on fenugreek seeds utilized a variety of forms of fenugreek seed viz., powder of fenugreek seed, various extracts of fenugreek seeds, fenugreek seeds in diet/feed, and isolated phytoconstituents from fenugreek seed. Twenty-four studies were conducted on the isolated phytoconstituents, 16 studies used fenugreek seed extract, and 5 studies used fenugreek seeds that was included in the diet/feed ([Table 3](#tbl3){ref-type="table"}).Table 3Characteristics of included *In-vivo* studies.Table 3Sr. No.AuthorsStudy conducted according to recent guidelinesSpecies/test system usedDose of test compoundDuration of exposure of test compound (in days)Isolated/extract/powder/diet1Ahirwar et al. (2010)NoWistar rats500 mg/kg7 daysExtract2Al-Ashban et al. (2010)Yes (W.H.O. protocol, 1967)Swiss albino miceAcute dosages: 0.5, 1.0 and 3 g/kg\
Chronic dosage: 100 mg/kgAcute (24 h) and chronic (90 days)Extract3Al-Shaikh et al. (1999)NoGoat25 or 50% fenugreek63 daysDiet4Al-Yahya (2013)NoSwiss albino Mice153, 305 and 610 mg/kg90 daysCapsules5Aswar et al. (2010)NoWistar rats10 and 35 mg/kg28 daysIsolated6Aswar et al. (2008)Yes (OECD-425)Wistar rats and Swiss albino Mice10 and 35 mg/kg28 daysIsolated7Aswar et al. (2009)NoWistar rats75 mg/kg7 daysIsolated8Awad et al. (2015)NoFish10 (1%), 50 (5%) or 100 (10%) g/kg28 daysDiet9Bin-Hafeez et al. (2003)NoSwiss albino mice50, 100 and 250 mg/kg10 daysExtract10Chevassus et al. (2009)Yes (ICH-GCP)Human subject588 mg (app. 8 mg/kg)14 daysDry hydro-alcoholic extract in tablets11Choudhary et al. (2001)NoSwiss albino mice1, 2, 5 and 10%28 daysDiet12Dande and Patil (2012)Yes (OECD-423)Wistar rats2000 mg/kg1 daySaponin extract13Deshpande et al. (2017a)Yes (OECD-423 and OECD-408)Wistar ratsAOT: 300 and 2000 mg/kg\
90-day repeated dose toxicity: 250, 500, and 1000 mg/kgFor AOT: Single day\
For 90-day repeated dose toxicity: 90 daysIsolated14Deshpande et al. (2016a)Yes (OECD-414)Wistar rats250, 500 and 1000 mg/kg20 daysIsolated15Deshpande et al. (2016b)Yes (OECD-414)Wistar rats250, 500 and 1000 mg/kg20 daysIsolated16Deshpande et al. (2017b)Yes (OECD-414)Wistar rats250, 500 and 1000 mg/kg20 daysIsolated17Deshpande et al. (2016c)Yes (OECD-423 and OECD-408)Wistar ratsAOT: 2000 mg/kg\
For 90-day repeated dose toxicity: 250, 500, and 1000 mg/kgFor AOT: Single day\
For 90-day repeated dose toxicity: 90 daysIsolated18Deshpande et al. (2017c)Yes (OECD-423 and OECD-408)Wistar ratsAOT: 2000 mg/kg\
For 90-day repeated dose toxicity: 250, 500, and 1000 mg/kgFor AOT: Single day\
For 90-day repeated dose toxicity: 90 daysIsolated19Deshpande et al. (2016d)Yes (OECD-423 and OECD-408)Sprague-Dawley ratsAOT: 2000 mg/kg\
For 90-day repeated dose toxicity: 250, 500, and 1000 mg/kgFor AOT: Single day\
For 90-day repeated dose toxicity: 90 daysIsolated20Effraim et al. (1999)NoWistar rats1, 1.5 and 2 g/kg28 daysExtract21Flammang et al. (2004)NoBR mice500, 1000 or 2000 mg/kg/day3 daysExtract22Folwarczna et al. (2014a)NoWistar rats50 mg of 4-hydroxy-L-isoleucine/kg28 daysDiet23Folwarczna et al. (2014b)NoWistar rats50 mg/kg28 daysIsolated24Kandhare et al. (2015)Yes (OECD-425 and OECD-407)Swiss albino miceAOT: 55, 175, 550, 1750 and 5000 mg/kg, Repeated dose 28-day oral toxicity: 250, 500, 1000 mg/kgFor AOT: Single day\
For 28-day repeated dose toxicity: 28 daysIsolated25Kandhare et al. (2016a)Yes (OECD-425 and OECD-407)Swiss albino miceAOT: 55, 175, 550, 1750 and 5000 mg/kg, Repeated dose 28-day oral toxicity: 37.5, 75, 150 mg/kgFor AOT: Single day\
For 28-day repeated dose toxicity: 28 daysIsolated26Kassem et al. (2006)NoNew Zealand white rabbitsFenugreek seed powder diet (30%)90 daysDiet27Khalki et al. (2013)NoSwiss CD1 mice1 g/kg/dayGestation period of mice is usually 19--21 daysExtract28Khalki et al. (2010)NoSwiss albino mice500 and 1000 mg/kgGestation period of mice is usually 19--21 daysExtract29Maheshwari et al. (2017)Yes (ICH-GCP)Human subject500 mg/day90 daysIsolated30Majumdar et al. (2017)NoWistar rats0.25 g/kg28 daysIsolated31Mokashi et al. (2014)NoHuman subject600 mgAcute StudyIsolated32Panda et al. (1999)NoSwiss albino mice0.11 g/kg15 daysExtract33Petit et al. (1995)NoWistar rats12.5 mg/300 g28 daysIsolated34Poole et al. (2010)NoHuman subject500 mg56 daysIsolated35Rao et al. (2015)NoHuman subject600 mgOver two menstrual cyclesIsolated36Rao et al. (2016)NoHuman subject600 mg90 daysExtract37Sharma (1986)NoHuman subject25 gAcuteExtract38Steels et al. (2011)NoHuman subject600 mg42 daysIsolated39Swaroop et al. (2014)Yes (OECD-407 and OECD-471)Wistar rats and Swiss albino MiceAcute: 0, 500, 1000 and 2000 mg/kg\
28-day: 0, 250, 500 and 1000 mg/kgAOT: Single day\
28-day repeated dose toxicity: 28 daysIsolated40Wankhede et al. (2016)Yes (Guidelines of Helsinki Declaration)Human subject600 mg56 daysIsolated41Wilborn et al. (2010)NoHuman subject500 mg56 daysIsolated42Mowla et al. (2009)NoWistar rats3 g/kgAcute studyExtract43Hamad et al. (2017)NoSwiss albino mice3, 6, and 9 g/kgAcute studyExtract44Wilborn et al. (2017)NoHuman subject450 mg14 daysIsolated45Hamad et al. (2017)YesSwiss albino mice3, 6, and 9 g/kgAcute studyExtract[^1]Table 4Characteristics of included *In-vitro* studies.Table 4Sr. No.AuthorsStudy conducted according to recent guidelineSpecies/Test system usedDose of test compound1Deshpande et al. (2017a)Yes (OECD-471 and OECD-473)*Salmonella typhimurium*50, 150, 500, 1,500, and 5,000 μg/plate2Deshpande et al. (2016c)Yes (OECD-471)*Salmonella typhimurium*5000.00, 1666.67, 555.55, 185.18 and 61.72 μg/plate3Deshpande et al. (2017c)Yes (OECD-471)*Salmonella typhimurium*5000.00, 1666.67, 555.55, 185.18 and 61.72 μg/plate4Flammang et al. (2004)No*Salmonella typhimurium*33.3, 100, 333, 1000, 3330, 5000 μg/plate5Swaroop et al. (2014)Yes (OECD-471)*Salmonella typhimurium*5000, 1500, 500, 150 and 50 μg/plate[^2]

3.2. Inter-rater consistency reliability {#sec3.2}
----------------------------------------

The inter-rater consistency was measured by Cronbach\'s alpha coefficient amongst the three raters viz. PAT, ADK, PW for scoring the ToxRTool. For combined score, the inter-rater consistency reliability was 0.920 which means there was 92.0% agreement between the raters. Whereas for weighted score, inter-rater consistency reliability was 0.887 which means there was 88.7% agreement between the raters.

3.3. Reliability categorizations {#sec3.3}
--------------------------------

Tables [5](#tbl5){ref-type="table"} and [6](#tbl6){ref-type="table"} summarize the ToxR reliability assessment score for individual *in-vivo* and *in-vitro* toxicity studies, respectively. For the 45 evaluated *in-vivo* studies, 23 were determined to be "Reliable Without Restriction" (51%), 13 determined to be "Reliable With Restriction" (29%), and 9 were determined to be "Not Reliable" (20%) based on their initial category score. However, checking of red scores (weighted scores) lead to a revision in the categories which now contained 17 studies under "Reliable Without Restriction" (38%), and 28 studies under "Not Reliable" (62%) ([Fig. 2](#fig2){ref-type="fig"}).Table 5ToxR reliability assessment scores for individual *in-vivo* toxicity studies.Table 5Sr. No.AuthorsCriteria group I (Mean ± SD)Criteria group II (Mean ± SD)Criteria group III (Mean ± SD)Criteria group IV (Mean ± SD)Criteria group V (Mean ± SD)Combined score (Mean ± SD)Weighted score (Mean ± SD)Initial category (Based on mean combined score)Revised category (Based on mean weighted score)1Ahirwar et al. (2010)0.00 ± 0.005.00 ± 0.005.00 ± 1.001.67 ± 0.570.00 ± 0.0011.67 ± 1.525.00 ± 1.00332Al-Ashban et al. (2010)1.33 ± 0.575.00 ± 0.005.33 ± 0.5771.67 ± 0.570.67 ± 1.1514.00 ± 2.646.67 ± 1.15233Al-Shaikh et al. (1999)0.33 ± 0.573.67 ± 0.574.00 ± 3.462.33 ± 0.571.33 ± 0.5711.66 ± 3.216.33 ± 0.57334Al-Yahya (2013)1.00 ± 1.005.00 ± 0.005.33 ± 1.522.67 ± 0.571.00 ± 1.0015.00 ± 4.006.33 ± 1.52235Aswar et al. (2010)4.00 ± 0.005.00 ± 0.005.33 ± 0.573.00 ± 0.002.00 ± 0.0019.33 ± 0.577.33 ± 0.57136Aswar et al. (2008)1.67 ± 0.575.00 ± 0.004.67 ± 0.573.00 ± 0.002.00 ± 0.0016.33 ± 0.576.33 ± 0.57237Aswar et al. (2009)2.67 ± 0.575.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0018.67 ± 0.578.00 ± 0.00118Awad et al. (2015)1.67 ± 0.574.33 ± 0.576.33 ± 0.572.67 ± 0.571.00 ± 0.0016.00 ± 0.007.00 ± 0.00239Bin-Hafeez et al. (2003)2.00 ± 0.005.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0018.00 ± 0.007.33 ± 0.571310Chevassus et al. (2009)3.67 ± 0.575.00 ± 0.005.67 ± 0.573.00 ± 0.002.00 ± 0.0019.33 ± 0.577.67 ± 0.571311Choudhary et al. (2001)0.67 ± 0.575.00 ± 0.006.00 ± 0.003.00 ± 0.001.00 ± 0.0015.67 ± 0.576.33 ± 0.572312Dande and Patil (2012)1.67 ± 1.524.67 ± 0.574.33 ± 1.521.33 ± 1.520.33 ± 0.5712.33 ± 5.506.00 ± 2.003313Deshpande et al. (2017a)4.00 ± 0.005.00 ± 0.006.67 ± 0.573.00 ± 0.002.00 ± 0.0020.67 ± 0.578.00 ± 0.001114Deshpande et al. (2016a)4.00 ± 0.005.00 ± 0.006.67 ± 0.573.00 ± 0.002.00 ± 0.0020.67 ± 0.578.00 ± 0.001115Deshpande et al. (2016b)4.00 ± 0.005.00 ± 0.006.67 ± 0.573.00 ± 0.002.00 ± 0.0020.67 ± 0.578.00 ± 0.001116Deshpande et al. (2017b)4.00 ± 0.005.00 ± 0.006.67 ± 0.573.00 ± 0.002.00 ± 0.0020.67 ± 0.578.00 ± 0.001117Deshpande et al. (2016c)4.00 ± 0.005.00 ± 0.006.67 ± 0.573.00 ± 0.002.00 ± 0.0020.67 ± 0.578.00 ± 0.001118Deshpande et al. (2017c)4.00 ± 0.005.00 ± 0.006.33 ± 0.573.00 ± 0.002.00 ± 0.0020.3.00 ± 0.578.00 ± 0.001119Deshpande et al. (2016d)4.00 ± 0.005.00 ± 0.006.33 ± 0.573.00 ± 0.002.00 ± 0.0020.33 ± 0.578.00 ± 0.001120Effraim et al. (1999)1.00 ± 0.004.33 ± 0.575.67 ± 0.570.00 ± 0.000.00 ± 0.0011.00 ± 1.005.67 ± 0.573321Flammang et al. (2004)1.33 ± 1.154.33 ± 0.576.00 ± 0.002.67 ± 0.570.67 ± 1.1515.00 ± 3.007.00 ± 1.002322Folwarczna et al. (2014a)3.67 ± 0.574.67 ± 0.576.00 ± 0.002.33 ± 1.150.67 ± 0.5717.33 ± 2.086.67 ± 0.572323Folwarczna et al. (2014b)4.00 ± 0.004.67 ± 0.576.00 ± 0.003.00 ± 0.002.00 ± 0.0019.67 ± 0.578.00 ± 0.001124Kandhare et al. (2015)4.00 ± 0.005.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0020.00 ± 0.008.00 ± 0.001125Kandhare et al. (2016a)4.00 ± 0.005.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0020.00 ± 0.008.00 ± 0.001126Kassem et al. (2006)1.67 ± 1.523.33 ± 1.154.33 ± 2.083.00 ± 0.000.00 ± 0.0012.33 ± 4.725.67 ± 2.303327Khalki et al. (2013)3.00 ± 0.005.00 ± 0.006.00 ± 0.002.67 ± 0.570.67 ± 1.1517.33 ± 1.527.33 ± 0.572328Khalki et al. (2010)2.33 ± 1.154.67 ± 0.576.00 ± 0.002.33 ± 1.150.67 ± 1.1516.00 ± 3.607.00 ± 1.002329Maheshwari et al. (2017)4.00 ± 0.005.00 ± 0.004.00 ± 1.002.67 ± 0.572.00 ± 0.0017.67 ± 1.526.00 ± 1.002330Majumdar et al. (2017)3.33 ± 1.154.33 ± 0.575.33 ± 1.152.67 ± 0.571.33 ± 0.5717.00 ± 3.607.00 ± 1.002331Mokashi et al. (2014)2.67 ± 0.575.00 ± 0.006.33 ± 0.573.00 ± 0.002.00 ± 0.0019.00 ± 0.007.33 ± 0.571332Panda et al. (1999)1.33 ± 0.575.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0017.33 ± 0.577.00 ± 0.002333Petit et al. (1995)3.67 ± 0.575.00 ± 0.005.67 ± 0.573.00 ± 0.001.33 ± 1.1518.67 ± 2.307.33 ± 1.151334Poole et al. (2010)4.00 ± 0.005.00 ± 0.005.33 ± 0.573.00 ± 0.002.00 ± 0.0019.33 ± 0.577.33 ± 0.571335Rao et al. (2015)4.00 ± 0.005.00 ± 0.006.00 ± 0.002.67 ± 0.571.67 ± 0.5719.3 3 ± 1.158.00 ± 0.001136Rao et al. (2016)1.00 ± 0.005.00 ± 0.003.00 ± 0.002.33 ± 0.570.00 ± 0.0011.33 ± 0.575.00 ± 0.003337Sharma (1986)2.00 ± 0.004.33 ± 1.156.67 ± 0.572.33 ± 1.151.00 ± 1.0016.33 ± 3.787.33 ± 1.152338Steels et al. (2011)2.00 ± 1.005.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0018.00 ± 1.008.00 ± 0.001139Swaroop et al. (2014)4.00 ± 0.005.00 ± 0.006.00 ± 0.002.67 ± 0.572.00 ± 0.0019.67 ± 0.578.00 ± 0.001140Wankhede et al. (2016)4.00 ± 0.005.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0020.00 ± 0.008.00 ± 0.001141Wilborn et al. (2010)2.33 ± 1.155.00 ± 0.006.33 ± 0.572.67 ± 0.572.00 ± 0.0018.33 ± 0.578.00 ± 0.001142Mowla et al. (2009)1.00 ± 0.004.00 ± 0.006.33 ± 0.570.67 ± 0.570.00 ± 0.0012.00 ± 0.007.00 ± 0.003343Hamad et al. (2017)0.00 ± 0.004.00 ± 0.003.00 ± 0.000.67 ± 1.160.00 ± 0.007.67 ± 1.164.00 ± 0.003344Wilborn et al. (2017)3.00 ± 0.005.00 ± 0.007.00 ± 0.003.00 ± 0.002.00 ± 0.0020.00 ± 0.008.00 ± 0.001145Hamad et al. (2017)0.00 ± 0.004.33 ± 0.563 ± 00.33 ± 0.580.00 ± 0.007.67 ± 1.154.00 ± 0.0033[^3]Table 6ToxR reliability assessment scores for individual *in-vitro* toxicity studies.Table 6Sr. No.AuthorsCriteria group I (Mean ± SD)Criteria group II (Mean ± SD)Criteria group III (Mean ± SD)Criteria group IV (Mean ± SD)Criteria group V (Mean ± SD)Combined score (Mean ± SD)Weighted score (Mean ± SD)Initial category (Numerical result)Revised categories after checking red scores1Deshpande et al. (2017a)4.00 ± 0.002.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0017.00 ± 0.006.00 ± 0.00112Deshpande et al. (2016c)4.00 ± 0.002.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0017.00 ± 0.006.00 ± 0.00113Deshpande et al. (2017c)4.00 ± 0.002.00 ± 0.006.00 ± 0.003.00 ± 0.002.00 ± 0.0017.00 ± 0.006.00 ± 0.00114Flammang et al. (2004)1.33 ± 1.153.00 ± 0.006.00 ± 0.003.00 ± 0.000.00 ± 0.0013.33 ± 1.154.67 ± 0.57235Swaroop et al. (2014)4.00 ± 0.002.33 ± 0.575.33 ± 1.153.00 ± 0.002.00 ± 0.0016.67 ± 0.575.33 ± 1.1513[^4]Fig. 2Number of *in-vivo* studies in the combined score (A) and weighted score (B) categorization.Fig. 2

Of the five evaluated *in-vitro* studies, four were determined to be "Reliable Without Restriction" (80%), and one was determined to be "Reliable With Restrictions," (20%). However, when they were checked for their red scores (revised category), three studies found to be "Reliable Without Restriction" (60%) and two studies were "Not Reliable" (40%) ([Fig. 3](#fig3){ref-type="fig"}). Three studies were having the highest combined score as well as weighted score amongst five evaluated *in-vitro* studies \[[@bib8], [@bib33], [@bib35]\].Fig. 3Number of *in-vitro* studies in the combined score (A) and weighted score (B) categorization.Fig. 3

3.4. The effects of identification of the test material based on the average combined score and weighted score {#sec3.4}
--------------------------------------------------------------------------------------------------------------

Univariate analysis showed that the identified category i.e., studies which have used identified study material or studies which have used isolated phytoconstituents, have significant difference (*p* \< 0.0001) for average combined score (i.e., initial category score) and weighted score (i.e., revised category score) as compared to non-identified study material or studies which have been carried out on fenugreek seed extract or diet/feed.

3.5. The effect of compliance with guidelines based on the average combined score and weighted score {#sec3.5}
----------------------------------------------------------------------------------------------------

The toxicity studies which have been conducted according to the guidelines such as OECD (Organization for Economic Co-operation and Development) or ICH-GCP (International Conference on Harmonization-Good Clinical Practice) have a significant difference (*p* \< 0.05) for an average combined score and a weighted score of scores as compared to studies where guidelines are not followed.

3.6. The correlations of various criteria groups with an average combined score {#sec3.6}
-------------------------------------------------------------------------------

The Pearson correlation between an average combined score and scores for the groups I (i.e., test substance identification), III (i.e., study design description) and V (i.e., the plausibility of study design and results) were found to be 0.875, 0.734, and 0.905 respectively. The Kendall rank correlation coefficient (Kendall\'s tau-b) of criteria for the groups I, III, and V with the average combined score was found to be 0.764, 0.551, and 0.752 respectively. The average of total score of group I, III, and V has a significant effect (*p* \< 0.05) on average of combined score.

3.7. The outcome of fenugreek seed toxicological studies that are categorized as "Reliable without restrictions." {#sec3.7}
-----------------------------------------------------------------------------------------------------------------

The outcome from the studies categorized as "Reliable without restrictions" is presented in [Table 7](#tbl7){ref-type="table"}. All these seventeen studies used identified study material (standardized fenugreek seed extract with identified marker compounds) for evaluation of fenugreek seed toxicity.Table 7The outcome of fenugreek seed toxicological studies that are categorized as 'Reliable without restrictions'.Table 7Sr. No.AuthorsOutcomes1.Aswar et al. (2009)The lack of abortifacient activity or teratogenicity confirms the *safety* of trigonelline during pregnancy in rats2.Deshpande et al. (2017a)The furostanol saponin glycoside based standardized fenugreek seed extract (Fenu-FG) was found *safe* during preclinical safety assessments3.Deshpande et al. (2016a)The prenatal oral exposure of Fenu-FG was *devoid* of maternal or developmental *fetotoxicity or teratogenicity*4.Deshpande et al. (2016b)Oral exposure of low molecular weight galactomannans based standardized fenugreek seed extract (LMWGAL-TF) during the prenatal period *did not* induce significant maternal and embryo-fetal *toxicity*5.Deshpande et al. (2017b)*None* of the Glycoside-based standardized fenugreek seed extract (SFSE-G)-treated groups showed maternal and embryo-fetal *toxicity*6.Deshpande et al. (2016c)SFSE-G was found *safe* for acute and sub-chronic administration in rats with no mutagenic potential7.Deshpande et al. (2017c)IDM01 (the botanical composition of 4-hydroxyisoleucine- and trigonelline-based standardized fenugreek) was found *safe* during preclinical acute and sub-chronic toxicity in rats without mutagenicity or genotoxicity8.Deshpande et al. (2016d)LMWGAL-TF was found *safe* during acute and sub-chronic toxicity studies in rats with no mutagenicity9.Folwarczna et al. (2014b)Administration of trigonelline *did not affect* the investigated parameters in non-ovariectomized rats10.Kandhare et al. (2015)SFSE-G was found *safe* for acute and subacute administration in rats11.Kandhare et al. (2016a)Vicenin-1 was found *safe* for acute and subacute administration in rats12.Rao et al. (2015)*T. foenum-graecum* seed extract is a *well-tolerated* and is an effective botanical medicine for use in the support of sexual function of pre-menopausal women13.Steels et al. (2011)There were *no adverse events* recorded during the clinical trial. The Testofen, a standardized *Trigonella foenum-graecum* (Fenugreek) extract was *well tolerated.*14.Swaroop et al. (2014)After extensive *in-vitro* and *in-vivo* safety and efficacy studies it has been concluded that novel fenugreek extract (FE), Fenfuro^TM^ is *safe* and effective in treating type 2 diabetes.15.Wankhede et al. (2016)The Fenu-FG supplementation was found to be *safe* and *well-tolerated.*16.Wilborn et al. (2010)*T. foenum-graecum* appears *safe* when taken over an 8-week time period17.Wilborn et al. (2017)IBPR was found to be safe and well tolerated

4. Discussion {#sec4}
=============

There are a large number of clinical and preclinical published evidence available on the toxicological and safety profile of fenugreek seed. However, several considerations such as nature of study material, variable experimental designs, conflicting results, etc. affect the safety outcomes. There are few reviews available which summarize the toxicological outcomes of these fenugreek toxicity studies \[[@bib9], [@bib10]\]. However, the utility of these reviews for risk assessment is limited as they have summarized results without any consideration of critical assessment of the quality of the studies. Hence, in the present investigation three-independent raters systematically evaluated available evidence of fenugreek seed toxicological studies by using the ToxRTool. This approach consists of (1) identification or characterization of the fenugreek seed or isolated substance from it, (2) compositional analysis of the fenugreek seed feed, (3) study design carried out according to the international guidelines, and (4) good quality of study results or adverse event reporting in toxicology studies. The outcome of the present study provided a transparent and comprehensive assessment of *in-vivo* and *in-vitro* published evidence on fenugreek seed toxicological studies with a critical assessment using the ToxRTool.

In the present study, ToxRTool was employed to provide a transparent method for risk assessment of the published evidence. Evaluation of published toxicity studies using ToxRTool provided important information about the critical components of the evaluation of toxicological data reliability and possible sources of heterogeneity which affect the outcome of the evaluation. Animal feeding studies are widely accepted for assessment of risks for human food consumption thus, a thorough search of the literature has been conducted to identify fenugreek seed toxicological studies as many as possible.

The chemical structure of the compound is a key determinant of the potential of toxicity [@bib60]. Thus, chemical characterization of food chemical or food component needs to be an initial step towards its toxicological evaluation. The availability of technical information of a structure of the compound can provide valuable insight, for instance, irritability, bioaccumulation or any inhalation hazard, etc. [@bib61]. The technical information includes any common names, trade names, Chemical Abstracts Service (CAS) number, chemical name, chemical composition, degree of purity, solubility, physical form, presence of any known impurities along with its nature, physicochemical properties such as pH, pKa, melting point, boiling point, vapour pressure and partition coefficient and stability. In addition to technical information, description of the manufacturing process, the presence of any complex mixtures and reliable analytical methods for detection or quantification of the test substance may provide important basis for reliable toxicological information [@bib61]. Thus, the inclusion of comprehensive and clear information of test substance needs to be ensured for reliable safety information.

In the present study, the toxicological studies in which such comprehensive technical information of extract (either aqueous, hydro-alcoholic, alcoholic or petroleum ether) were not identified, showed low combined score and fell under category 3, i.e., "Not Reliable". On the other hand, the toxicological studies, in which clear identification of composition of fenugreek seeds was reported, that studies showed higher combined score (≥18) and fell in the category '1' i.e., "Reliable Without Restrictions". These were further supported by the correlation analyses (Pearson as well as Kendall rank correlation coefficient), i.e., criteria group I (i.e., test substance identification) showed good correlation with combined scores. These results strongly delineate the importance of identification of the test substance on the quality and reliability of toxicity study.

The implementation of animal-based methods for determination of hazard is an important component of human risk assessment [@bib62]. Hence, the selection of animal species for determination of toxicity is an important aspect for clinical toxicological relevance. Moreover, the practicality of animal model such as ease of assessment, availability of background data, ease of use, etc., also played a significant role in toxicity evaluation. Furthermore, it has been reported that obtaining maximum information by utilizing a minimum number of animals is generally emphasized during toxicological evaluations [@bib61]. These can be achieved by using either sex, implementing multiple species (such as mice and rats), the use of higher and multiple doses which are higher than anticipated human exposure and administration of dose over a long duration which covers the complete life cycle. These careful considerations affect the toxicological outcomes of test compounds. In the present review, the selected fenugreek seed toxicity studies have used various species such as albino and Swiss mice, Wistar and Sprague-Dawley rats, goat, fish, New Zealand white rabbits, healthy human volunteers, etc. Most of the toxicological studies reported the test organism characterization well. Thus, the findings from ToxRTool showed that total score of group II (i.e., test organism characterization) did not have any significant effect on average combined scores or reliability category of the study.

The minimum number of animals per dose group is another important aspect of quality animal study concerning statistical analysis. The OECD guideline 414 [@bib63] recommends consideration for usage of a sufficient number of animals. Furthermore, the quality of the outcome data depends on the various animal-related factors including health of the animal stock, variability of animals, environmental condition of the laboratory and animal house, quality of diet, nutritional adequacy of diet, and the qualifications and experience of the staff [@bib61]. The finding of the present study showed a good correlation (Pearson) criteria group III (i.e., study design description) with a combined score and a weighted score of ToxRTool.

The repeated dose toxicity studies are undertaken with an objective to determine any possible adverse effect of the test compound, on long-term (subacute, sub-chronic or chronic) toxicities and to determine the no-observed-adverse-effect level (NOAEL) and lowest-observed-adverse-effect level (LOAEL). NOAEL and LOAEL form an important base for determination of maximum tolerable daily intakes and dose-response relationships [@bib64]. During repeated dose toxicity study, test substance administration in the form of diet/feed is common because of its relevance to oral intake in humans. Additionally, administration of test substance in drinking water is correlated well with use as beverages. However, administration via diet/feed or drinking water has the limitation that the exact dose and quantification of administered test substance can\'t be determined. Furthermore, administration of nutritionally unbalanced diets may result in adverse event which may conclude in negative toxicological outcomes \[[@bib65], [@bib66]\]. In the present study, five studies used the fenugreek seed in the form of diet \[[@bib23], [@bib27], [@bib38], [@bib41], [@bib55]\]. These studies did not report values for nutritional analysis of diet or food intake by the animal or subject and therefore may not yield reliable toxicology information. Thus, administration by oral gavage provides advantages over diet or drinking water. The results of the present study support the administration of study material by oral gavage over diet. In line with this notion, all 5 studies with diet route of administration were categorized under the category '3' and supported non-reliability of these studies.

The present study also considered "quality of study design" as an important aspect of the toxicological study. Additionally, the toxicology study outcomes were greatly influenced by the extent of details and quality of data analysis. Hence, selection of robust and appropriate statistical analysis methods is important for the toxicological study outcomes [@bib61] and is considered in the international guidelines. Therefore, studies which have been conducted according to international guidelines for toxicology are expected to have robust experimental design and data analysis. This notion is supported by the results of the present study where studies with good quality of study-design are categorised as category 1 ('Reliable Without Restriction') or 2 ('Reliable with Restriction'). Conversely, the studies that are not conducted as per principals of GLP (Good laboratory practice) and did not follow international guidelines were assigned to the category 3 ('Not Reliable'). Furthermore, scores of criteria group V (i.e., the plausibility of study design and results) have a good Pearson correlation (0.905) with the combined score and also have a significant effect (*p* \< 0.05) on combined score.

Animal-based *in-vivo* toxicological evaluation is a good predictor of hazards to human health [@bib67]. However, it has limited predictability for carcinogenicity and developmental toxicity potential due to a limited number of known carcinogens and teratogens with their species-specific responses of animals [@bib68]. Therefore, *in-vitro* mutagenicity (Ames test) study (OECD No. 471) can provide the dose-response data for hazard identification and risk assessment for carcinogenicity and mutagenicity [@bib67]. Furthermore, *in-vitro* genotoxicity (chromosomal aberrations test) (OECD No. 473) is a reliable and validated method for reproductive and developmental toxicity testing. In the present study, five toxicological studies on fenugreek seed extract investigated *in-vitro* mutagenicity and genotoxicity. 3 out of the 5 *in-vitro* studies were conducted according to international guidelines and were found to fall under category 1, i.e. 'Reliable Without Restriction' \[[@bib8], [@bib33], [@bib35]\].

The reliability of toxicological study outcomes largely depends on integrity and quality conduct of the studies [@bib61]. Over the last two decades, toxicological studies which were carried out according to the international guidelines such as WHO protocol, OECD, or ICH-GCP have much reassurance for study outcomes. The guidelines help to ensure good experimentation and provide quality and consistent outcome data. Nevertheless, other toxicological studies which have not been conducted with such guidelines also provided useful results. However, such studies need to be considered with caution for toxicity risk assessment. In this regard, the assessments based on ToxRTool can be valuable. Amongst the toxicological studies that were conducted as per guidelines, 17 (38%) of studies were considered as 'Reliable Without Restrictions' and remaining 28 (62%) studies were considered as 'Not Reliable'. The present study found that fenugreek toxicity publications \[[@bib6], [@bib8], [@bib20], [@bib25], [@bib29], [@bib30], [@bib32], [@bib33], [@bib34], [@bib35], [@bib40], [@bib44], [@bib52], [@bib53]\] that are conducted according to the international guidelines produce more reliable results.

The present study utilized the ToxRTool tool to assess the reliability and relevance of published toxicological studies by three raters. During such assessments, heterogeneity can result from differences in raters\' experience and their interpretation of criteria [@bib69]. Therefore, we conducted an inter-rater reliability analysis to determine the extent to which variation exists between different raters by using validated instrument to obtain similar outcomes. Inter-rater reliability also ensures that the stability of generated data resulted in the form of observational analysis. In this study, three independent reviewers (PAT, ADK, PW) assessed individual fenugreek seed toxicological studies by using ToxRTool. Inter-rater consistency reliability for the three raters was 0.920, i.e., 92.0 % agreement between the raters for a combined score. If rating would have been done by a single rater, then the interclass correlation coefficient for the single measure would be 0.794. Therefore, in the present study use of three raters for scoring instead of single rater resulted in a 12.6% increase in correlation in combined scores. Similarly, for weighted score, a single rater would have resulted in an interclass correlation coefficient of 0.724, whereas three raters provided an additional 16.3% correlation amount weighted scores. Therefore, the average combined score and the average weighted score was used for further analysis.

In the present ToxR evaluation, analysis of conclusions of all the toxicological studies that were identified as Category 1 ('Reliable without restrictions') suggested a broad margin of safety for long-term duration ([Table 7](#tbl7){ref-type="table"}). All these studies utilized standardized test compound from fenugreek seed with well-identified marker ([Table 7](#tbl7){ref-type="table"}). Hence, the results of the present study emphasize the need to use the well-identified compounds in toxicological studies for reliable outcome.

There are some limitations existing in the present investigation and should be considered into account while interpreting the results of present findings. Firstly, the study did not analyze the published toxicological literature on parts of fenugreek plant other than seeds. Furthermore, any unavailable or missing information, or publication bias in reporting toxicological studies have not been taken into consideration.

5. Conclusions {#sec5}
==============

The comprehensive analysis of fenugreek seed toxicity studies using ToxRTool suggested a systematic approach that was found useful to evaluate the quality of published toxicological studies for health risk assessment. In the present study, toxicological publications on fenugreek seeds that are categorized as 'Reliable without restrictions' can be considered for toxicological risk assessment with reasonable certainty. The toxicological studies that are categorized as 'Reliable with restrictions' can be considered for toxicological risk analysis with caution especially concerning identification (characterization) of the compound. The studies categorized under category 3 (Not reliable) may not be useful for toxicological risk assessments.
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[^1]: AOT: Acute Oral Toxicity; ICH-GCP: International Conference on Harmonization-Good Clinical Practice; OECD: Organization for Economic Co-operation and Development.

[^2]: OECD: Organization for Economic Co-operation and Development.

[^3]: Data were represented as Mean ± SD.

[^4]: Data were represented as Mean ± SD.
